Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world vedolizumab IV in Japanese ulcerative colitis patients
jRCT1080225363Completed
- Sponsor
- Takeda
- Start
- Aug 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of vedolizumab in autoimmune colitis, sponsored by Takeda. Started Aug 2020; status: completed.
02
Drugs
vedolizumab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT1080225363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225363.